NASHVILLE, Tenn., Feb. 23, 2024 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced today that Company management will participate in Citi's 2024 Global Property CEO Conference on March 4, 2024 and Barclays Global Healthcare Conference on March 12, 2024.
On March 4, at the Citi Conference, the Brookdale roundtable presentation will begin at 6:30 am CST, and the live webcast can be accessed through the Company's website at brookdaleinvestors.com as well as by clicking here.
On March 12, at the Barclays Conference, the Brookdale fireside chat will begin at 12:35 pm CST, and the live webcast can be accessed through the Company's website as well as by clicking here.
A replay of the webcasts will be available on the Company's website until April 12, 2024.
About Brookdale Senior Living
Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. The Company is committed to its mission of enriching the lives of the people it serves with compassion, respect, excellence, and integrity. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities. Through its comprehensive network, Brookdale helps to provide seniors with care, connection, and services in an environment that feels like home. The Company's expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve wellness, pursue passions, make new friends, and stay connected with loved ones. Brookdale, through its affiliates, operates and manages 652 communities in 41 states as of December 31, 2023, with the ability to serve approximately 59,000 residents. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or YouTube.
Last Trade: | US$5.16 |
Daily Change: | 0.08 1.58 |
Daily Volume: | 251,976 |
Market Cap: | US$1.030B |
December 09, 2024 November 11, 2024 November 06, 2024 September 30, 2024 September 10, 2024 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB